Found 20 matching trials
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch PHASE3 Combination antiretroviral therapy (cART) HIV treatments are associated wit...
Show More Location
Mortimer Market Centre
Learn More & Join Trial
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study N/A This study aims to determine real-life clinical efficacy of virally suppres...
Show More Status
Active Not Recruiting
Location
Rijnstate Hospital
Learn More & Join Trial
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 PHASE4 Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patie...
Show More Location
Fundación Huésped
Learn More & Join Trial
Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE) PHASE3 Research hypothesis:
Switching from dual regimens based on dolutegravir pl...
Show More Location
Ospedale San Raffaele
Learn More & Join Trial
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH) PHASE4 This single-arm, open label study is aimed to assess efficacy and safety of...
Show More Location
Hospital General de Agudos Dr. Juan A. Fernández, Infectious Diseases Division
Learn More & Join Trial
B/F/TAF to DTG/3TC Switch Study PHASE3 OBJECTIVE:
To assess the efficacy and safety of switch to dolutegravir and...
Show More Status
Active Not Recruiting
Location
Jaramogi Oginga Odinga Teaching and Referral Hospital
Learn More & Join Trial
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF PHASE4 Phase 4, randomized, open-label study to evaluate the efficacy, safety and ...
Show More Location
Orlando Immunology Center
Learn More & Join Trial
Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women PHASE4 Protocol Number: FH-94
Study Objetives:
Primary:
* To evaluate the virol...
Show More Location
Hospital General de Agudos Dr. Cosme Argerich
Learn More & Join Trial
Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance PHASE3 This clinical trial will address the gap in published data on the effect of...
Show More Location
Jaramogi Oginga Odinga Teaching and Referral Hospital
Learn More & Join Trial
DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women PHASE3 The study aims to evaluate the safety and efficacy of a 2 drugs ART regimen...
Show More Location
Fundação Bahiana de Infectologia
Learn More & Join Trial